United States

Science Correspondent

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Apr 18 2018

INTERVIEW-Gates backs gene technologies in fight to end malaria

LONDON, April 18 Gene-editing technologies that alter mosquitoes' DNA could prove critical in the fight against malaria, Bill Gates said on Wednesday, and ethical concerns should not block progress in such gene-modifying research.

Apr 17 2018

Global leaders seek to reignite fight against deadly malaria

LONDON, April 18 Renewed action and boosted funding to fight malaria could prevent 350 million cases of the disease in the next five years and save 650,000 lives across commonwealth countries, health experts said on Wednesday.

Mar 16 2018

Deadly listeria could herald tighter food safety rules in South Africa

LONDON, March 16 A huge and deadly outbreak of listeria in South Africa could alter the country's approach to food-borne disease and prompt improvements in food safety standards, a leading health official said on Friday.

Feb 08 2018

Scientists grow human eggs to full maturity in a lab

LONDON, Feb 9 Scientists have succeeded for the first time in growing human eggs in a laboratory from the earliest stages in ovarian tissue all the way to full maturity - a scientific step that had previously been taken in mice.

Feb 01 2018

Health campaigners decry global HIV fund's deal with Heineken

LONDON, Feb 1 International health campaigners and alcohol concern groups called on a major global HIV and malaria fund on Thursday to end immediately a partnership it had signed with the Dutch brewer Heineken.

Dec 01 2017

Cancer drug prompts 'drastic' HIV decrease in lung cancer patient

LONDON, Dec 1 Doctors in France have found the first evidence that a drug normally used to treat lung, kidney or skin cancer may be able to eradicate HIV-infected cells in people with the AIDS virus.

Nov 28 2017

Europe's HIV epidemic growing at alarming rate, WHO warns

LONDON, Nov 28 The number of people newly diagnosed with HIV in Europe reached its highest level in 2016 since records began, showing the region's epidemic growing "at an alarming pace", health officials said on Tuesday.

Nov 23 2017

Avatars can help schizophrenia patients control threatening voices

By Kate Kelland, Health and Science Correspondent LONDON, Nov 23 An experimental therapy for people with schizophrenia that brings them face to face with a computer avatar representing the tormenting voices in their heads has proved promising in early stage trials.

Nov 13 2017

Bill Gates makes $100 million personal investment to fight Alzheimer's

LONDON, Nov 13 Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings together industry and government to seek treatments for the brain-wasting disease.

Nov 09 2017

Large U.S. farm study finds no cancer link to Monsanto weedkiller

LONDON, Nov 9 A large long-term study on the use of the big-selling weedkiller glyphosate by agricultural workers in the United States has found no firm link between exposure to the pesticide and cancer, scientists said on Thursday.


  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary